Have your own idea? Try our Stock Screener
UPDATED Jan 01, 2025
Discover Swedish Pharmaceuticals & Biotech Growth Stocks that are on the OMX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ATANA | SEK 0.007 | 0% | -93.3% | SEK 2.6m | n/a | PB0.3x | n/a | n/a | ||
DBP B | SEK 0.39 | -1.8% | -49.1% | SEK 41.5m | n/a | PS36.8x | n/a | n/a | ||
APTA | SEK 1.44 | 25.3% | -83.5% | SEK 8.1m | n/a | PS4.2x | n/a | n/a | ||
ACOU | SEK 11.35 | 3.2% | -29.3% | SEK 169.5m | SEK 18.00 | PS21.1x | S73.7% | n/a | ||
NICA | SEK 1.82 | -4.0% | -82.2% | SEK 160.8m | SEK 4.00 | PS18.3x | S95.5% | n/a | ||
ABERA | SEK 4.43 | -3.5% | -19.5% | SEK 68.0m | SEK 8.30 | PS5.4x | S-74.1% | n/a | ||
LIDDS | SEK 0.10 | -4.3% | -22.5% | SEK 13.6m | n/a | PS426.4x | n/a | n/a | ||
RESP | SEK 5.95 | -24.2% | -79.4% | SEK 30.3m | SEK 17.00 | PB0.9x | S39.5% | n/a | ||
PHARM | SEK 0.56 | -20.0% | -61.1% | SEK 9.7m | n/a | PS2.3x | n/a | n/a | ||
PMDS | SEK 0.66 | 0% | -94.5% | SEK 17.1m | n/a | PE-0.4x | S50.9% | n/a | ||
DANCAN | DKK 0.0026 | 8.3% | -88.2% | DKK 4.0m | n/a | PB0.3x | n/a | n/a | ||
PEXA B | SEK 0.22 | -0.9% | -44.1% | SEK 12.7m | n/a | PS16x | n/a | n/a | ||
COMBI | SEK 2.28 | -11.6% | -16.9% | SEK 45.1m | n/a | PS14.4x | n/a | n/a | ||
DICOT | SEK 0.27 | 22.5% | -33.3% | SEK 474.9m | n/a | PB38x | n/a | n/a | ||
ODI | SEK 2.50 | -12.0% | -50.0% | SEK 38.1m | n/a | PE115.2x | n/a | n/a | ||
IBT B | SEK 57.40 | 2.5% | -41.5% | SEK 773.3m | n/a | PS154651.9x | n/a | n/a | ||
BIOSGN | SEK 0.54 | -5.9% | -40.9% | SEK 125.9m | SEK 1.30 | PB10.8x | S123.8% | n/a | ||
CRNO B | SEK 5.72 | 5.6% | 22.9% | SEK 1.6b | n/a | PS18.6x | S-11.4% | n/a | ||
LEVBIO | SEK 0.23 | -9.4% | -45.0% | SEK 18.9m | n/a | PB2.9x | n/a | n/a |